# OnCo record autolus (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/autolus/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "autolus" ;
  schema:name "Autolus Therapeutics"@en ;
  schema:description "UCL spin-out whose fast-off-rate CD19 CAR-T, obe-cel, was approved for adult ALL in 2024 with lower neurotoxicity than earlier products."@en ;
  schema:url <https://onco.cc/companies/autolus/>, <https://www.autolus.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-obecabtagene-autoleucel-adults-relapsed-or-refractory-b-cell-precursor-acute> ;
  schema:addressCountry "GB" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:drugs <https://onco.cc/drugs/obecabtagene-autoleucel/> .